Collegium Pharma (COLL) Tops Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. ORCL
10. TFII

Go back to Collegium Pharma (COLL) Tops Q4 EPS by 3c

Collegium Reports Full-Year 2019 Revenue of $296.7 Million

February 27, 2020 4:02 PM EST

2019 Revenue Growth of 6%, Driven by Xtampza ER revenue growth of 51%

Xtampza® ER Prescriptions Grew 49% in 2019

Collegium Guides to Profitability in 2020

Conference Call Scheduled for Today at 4:30 p.m. ET

STOUGHTON, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) --  Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to... More